RICHMOND, Va., June 12, 2023 /PRNewswire/ — Indivior PLC INDV, a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses, today announces that the U.S. Securities & Exchange Commission (SEC) declared its registration statement on Form 20-F…Read More
Indivior to Commence Trading on Nasdaq Indivior OTCINVVY
